Medical Research News

RSS

Circulating molecules in the blood may be new markers of type 1 diabetes

Researchers from the Turku Bioscience Centre in Finland have found changes in molecules in the blood that might be new markers of type 1 diabetes. New findings may help understand the early pathogenesis of the disease.

19 Sep 2019

Blue-green algae pose threat to patients with liver disease

Researchers are calling for new guidelines for people with pre-existing liver disease who are exposed to a toxin released by blue-green algae.

19 Sep 2019

Contaminated tap water linked to more than 100,000 cancer cases in the US

Tap water contaminated with a toxic cocktail of chemical pollutants could be responsible for more than 100,000 cancer cases in the US over a lifetime.

19 Sep 2019

Teenage vaping rate doubles in two years

A new study has found that teenage vaping rates have doubled, revealing the largest recorded increase for 44 years.

19 Sep 2019

New and improved: CPR undergoes overhaul

An international study reviewed methods of cardiopulmonary resuscitation (CPR) in an attempt to save lives and reduce neurological damage.

19 Sep 2019

New uses for CBD in genetic brain disorder

A new study has revealed that cannabidiol can help people with a rare brain condition called Angelman syndrome to improve their behavioral traits and to control seizures.

19 Sep 2019

New protein could offer a fresh target for cancer treatment

A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.

19 Sep 2019

Researchers discover how cancer cells can trigger chronic muscle wasting condition

A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.

19 Sep 2019

Toxic algae may be more harmful for people with pre-existing liver disease

Toxins produced during harmful algal blooms may be more harmful to people than previously known.

19 Sep 2019

Promising new target regulating mitochondria during stress identified

Like an emergency response team that is called into action to save lives, stress response proteins in the heart are activated during a heart attack to help prevent cell death.

19 Sep 2019

Texas leads in worksite lactation support initiatives, research shows

Texas is ranked in the top quarter of the U.S. for its worksite lactation support initiatives, according to research led by The University of Texas Health Science Center at Houston School of Public Health.

19 Sep 2019

Diarrhea linked significantly to weight gain

A study has shown that obesity is linked to chronic diarrhea, independent of other lifestyle or eating habits.

19 Sep 2019

Spending on transitional housing for youth in foster care can help prevent homelessness, incarceration

State spending on transitional housing supports for youth "aging out" of foster care can make a big difference in preventing homelessness, incarceration, substance abuse and early childbirth, according to a new study by social work researchers at Case Western Reserve University.

19 Sep 2019

Study uncovers new factor in the development of childhood lymphoma

A study recently published in the renowned journal Blood, led by Kaan Boztug, Scientific Director of the St. Anna Children's Cancer Research Institute, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Adjunct Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Associate Professor at the Medical University of Vienna, together with scientists from Israel, Germany, Turkey, Colombia, Argentina and the USA, investigated four patients from independent families with malignancy, autoimmunity and immunodeficiency.

19 Sep 2019

All-in-one pill reduces estimated risk of cardiovascular disease, study shows

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25% in a study published today in the New England Journal of Medicine.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Using 3D virtual reality models to prepare for surgeries improves patient outcomes

A UCLA-led study has found that using three-dimensional virtual reality models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times, less blood loss during surgery and a shorter stay in the hospital afterward.

19 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Study may provide best intervention measures to prevent opioid overdose

A minority of people who use illicit opioids indicated a preference for fentanyl, the super-potent synthetic opioid that accounts for much of the recent rise in U.S. overdose deaths, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

19 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019